Does RIFAXIMIN Cause Hospitalisation? 1,605 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,605 reports of Hospitalisation have been filed in association with RIFAXIMIN (XIFAXAN). This represents 11.6% of all adverse event reports for RIFAXIMIN.
1,605
Reports of Hospitalisation with RIFAXIMIN
11.6%
of all RIFAXIMIN reports
198
Deaths
1,602
Hospitalizations
How Dangerous Is Hospitalisation From RIFAXIMIN?
Of the 1,605 reports, 198 (12.3%) resulted in death, 1,602 (99.8%) required hospitalization, and 5 (0.3%) were considered life-threatening.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIFAXIMIN. However, 1,605 reports have been filed with the FAERS database.
What Other Side Effects Does RIFAXIMIN Cause?
Death (3,687)
Therapy interrupted (875)
Off label use (802)
Diarrhoea (709)
Ammonia increased (676)
Inability to afford medication (672)
Insurance issue (577)
Confusional state (530)
Hepatic cirrhosis (480)
Hepatic encephalopathy (462)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which RIFAXIMIN Alternatives Have Lower Hospitalisation Risk?
RIFAXIMIN vs RILMENIDINE
RIFAXIMIN vs RILONACEPT
RIFAXIMIN vs RILPIVIRINE
RIFAXIMIN vs RILUZOLE
RIFAXIMIN vs RIMABOTULINUMTOXINB